Overview
Portfolio
More
Gokap
Gothenburg, Sweden
Invests in innovative West Swedish startups to generate returns and support regional entrepreneurs and the capital market.
Portfolio
19+
Employees
N/A
Founded
2018
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
Sweden
Sources
Showing 7 of 7 matched portfolio companies
Atium offers a patent-pending electrochemical technology to selectively remove dissolved mercury ions from dental wastewater. This system ensures regulatory compliance and reduces toxic pollution for dental practices. Its modular and scalable design provides an efficient and cost-effective solution for mercury abatement.
Cappy provides a mobile application that enables employees to access their earned wages in real-time, enhancing financial flexibility and reducing reliance on traditional pay cycles. This solution addresses high employee turnover and absenteeism by increasing motivation and productivity through immediate access to earned income.
Nanolyze offers instruments for real-time analysis of single nanoparticles and bulk material characterization. Their technology enables researchers to study the properties and behavior of nanoparticles with high precision.
Funding: $1.3M
Rough estimate of the amount of funding raised
Funding: $1.3M
Rough estimate of the amount of funding raised
Simsen Diagnostics utilizes SiMSen sequencing and two-tailed PCR to provide personalized cancer DNA testing from blood samples, enabling precise monitoring of unique tumor mutations. This technology enhances sensitivity and specificity in cancer detection, addressing the limitations of standardized testing methods.
The startup develops a biopharmaceutical treatment that utilizes pharmacotherapy to reduce alcohol consumption in patients with alcohol use disorder. This approach aims to enhance patients' quality of life while decreasing the associated health risks and societal costs of alcohol abuse.
Sortina Pharma develops small molecule therapeutics that target sortilin to eliminate treatment-resistant cancer stem cells, specifically focusing on triple-negative breast cancer and glioblastoma multiforme. This approach aims to prevent metastasis and enhance the efficacy of conventional therapies, addressing the critical challenge of cancer progression.
The startup develops a biomedical device that measures the potential difference in the muscle layer of the abdominal wall to detect involuntary muscle defense. This technology enables medical professionals to accurately diagnose various abdominal conditions, improving patient assessment and treatment outcomes.
Showing 12 of 12 unmatched portfolio companies